Drug information for BETAMETHASONE DIPROPIONATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CREAM, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA PHARMS 76215
CREAM, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 76543
CREAM, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PERRIGO NEW YORK 76592
CREAM, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TOLMAR 76603
CREAM, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate GLENMARK GENERICS 78930
CREAM; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PHARMADERM 19136
CREAM; TOPICAL EQ 0.05% BASE Prescription AB (Reference Drug) BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA PHARMS 19137
CREAM; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate ACTAVIS MID ATLANTIC 70885
CREAM; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 71143
CREAM; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TEVA 71476
CREAM; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PERRIGO NEW YORK 72536
CREAM; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 73552
CREAM; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PERRIGO NEW YORK 74579
2003-08-05 Review
GEL, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB (Reference Drug) BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA PHARMS 75276
2003-12-23 Review
2003-12-23 Letter
2003-12-23 Label
GEL, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 76508
LOTION, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA PHARMS 77111
2007-05-29 Letter
LOTION, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 77477
2007-05-29 Letter
LOTION; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PHARMADERM 70274
LOTION; TOPICAL EQ 0.05% BASE Prescription AB (Reference Drug) BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA 70275
LOTION; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate ACTAVIS MID ATLANTIC 70281
LOTION; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate ALPHARMA US PHARMS 71085
LOTION; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TEVA 71467
LOTION; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TEVA PHARMS 71882
LOTION; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 72276
LOTION; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PERRIGO NEW YORK 72538
LOTION; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 74272
OINTMENT, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate ACTAVIS MID ATLANTIC 74304
OINTMENT, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA PHARMS 75373
2002-01-17 Review
1999-06-22 Letter
OINTMENT, AUGMENTED; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 76753
OINTMENT; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PHARMADERM 19140
OINTMENT; TOPICAL EQ 0.05% BASE Prescription AB (Reference Drug) BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate FOUGERA 19141
OINTMENT; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate ACTAVIS MID ATLANTIC 71012
OINTMENT; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TEVA 71477
OINTMENT; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate PERRIGO NEW YORK 72526
OINTMENT; TOPICAL EQ 0.05% BASE Prescription AB  BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate TARO 74271

Drug Adverse Effects information for BETAMETHASONE DIPROPIONATE

Role code Indications Reaction # Reports
PS STEVENS-JOHNSON SYNDROME BRONCHIAL OBSTRUCTION 1
PS STEVENS-JOHNSON SYNDROME BRONCHITIS CHRONIC 1
PS STEVENS-JOHNSON SYNDROME CARDIAC DISORDER 1
PS STEVENS-JOHNSON SYNDROME RESPIRATORY FAILURE 1
SS CHRONIC MYELOID LEUKAEMIA UTERINE HAEMORRHAGE 1
SS CHRONIC MYELOID LEUKAEMIA VAGINAL HAEMORRHAGE 1
C ARTHRITIS ABDOMINAL PAIN UPPER 10
C ARTHRITIS GASTRITIS EROSIVE 5
C ARTHRITIS GASTROINTESTINAL HAEMORRHAGE 5
C ARTHRITIS HAEMATEMESIS 5
C ARTHRITIS INSOMNIA 10
C ARTHRITIS MALLORY-WEISS SYNDROME 5
C ARTHRITIS RENAL FAILURE ACUTE 5
C ASTHMA DUODENAL ULCER 1
C ASTHMA GASTRIC ULCER 1
C ASTHMA INJECTION SITE ERYTHEMA 1
C ASTHMA INJECTION SITE PAPULE 1
C ASTHMA INJECTION SITE REACTION 1
C ASTHMA PSORIASIS 1
C ATRIAL FIBRILLATION ABDOMINAL PAIN UPPER 2
C ATRIAL FIBRILLATION GASTRITIS EROSIVE 1
C ATRIAL FIBRILLATION GASTROINTESTINAL HAEMORRHAGE 1
C ATRIAL FIBRILLATION HAEMATEMESIS 1
C ATRIAL FIBRILLATION INSOMNIA 2
C ATRIAL FIBRILLATION MALLORY-WEISS SYNDROME 1
C ATRIAL FIBRILLATION RENAL FAILURE ACUTE 1
C BENIGN PROSTATIC HYPERPLASIA ABDOMINAL PAIN UPPER 2
C BENIGN PROSTATIC HYPERPLASIA GASTRITIS EROSIVE 1
C BENIGN PROSTATIC HYPERPLASIA GASTROINTESTINAL HAEMORRHAGE 1
C BENIGN PROSTATIC HYPERPLASIA HAEMATEMESIS 1
C BENIGN PROSTATIC HYPERPLASIA INSOMNIA 2
C BENIGN PROSTATIC HYPERPLASIA MALLORY-WEISS SYNDROME 1
C BENIGN PROSTATIC HYPERPLASIA RENAL FAILURE ACUTE 1
C BLOOD CHOLESTEROL INCREASED ABDOMINAL PAIN UPPER 2
C BLOOD CHOLESTEROL INCREASED GASTRITIS EROSIVE 1
C BLOOD CHOLESTEROL INCREASED GASTROINTESTINAL HAEMORRHAGE 1
C BLOOD CHOLESTEROL INCREASED HAEMATEMESIS 1
C BLOOD CHOLESTEROL INCREASED INSOMNIA 2
C BLOOD CHOLESTEROL INCREASED MALLORY-WEISS SYNDROME 1
C BLOOD CHOLESTEROL INCREASED RENAL FAILURE ACUTE 1
C CARDIAC DISORDER ABDOMINAL PAIN UPPER 3
C CARDIAC DISORDER GASTRITIS EROSIVE 1
C CARDIAC DISORDER GASTROINTESTINAL HAEMORRHAGE 1
C CARDIAC DISORDER HAEMATEMESIS 1
C CARDIAC DISORDER INSOMNIA 3
C CARDIAC DISORDER MALLORY-WEISS SYNDROME 1
C CARDIAC DISORDER RENAL FAILURE ACUTE 1
C CONSTIPATION ABDOMINAL PAIN UPPER 2
C CONSTIPATION GASTRITIS EROSIVE 1
C CONSTIPATION GASTROINTESTINAL HAEMORRHAGE 1
C CONSTIPATION HAEMATEMESIS 1
C CONSTIPATION INSOMNIA 2
C CONSTIPATION MALLORY-WEISS SYNDROME 1
C CONSTIPATION RENAL FAILURE ACUTE 1
C DIABETES MELLITUS DUODENAL ULCER 1
C DIABETES MELLITUS GASTRIC ULCER 1
C DIABETES MELLITUS INJECTION SITE ERYTHEMA 1
C DIABETES MELLITUS INJECTION SITE PAPULE 1
C DIABETES MELLITUS INJECTION SITE REACTION 1
C DIABETES MELLITUS PSORIASIS 1
C EYE DISORDER ABDOMINAL PAIN UPPER 2
C EYE DISORDER GASTRITIS EROSIVE 1
C EYE DISORDER GASTROINTESTINAL HAEMORRHAGE 1
C EYE DISORDER HAEMATEMESIS 1
C EYE DISORDER INSOMNIA 2
C EYE DISORDER MALLORY-WEISS SYNDROME 1
C EYE DISORDER RENAL FAILURE ACUTE 1
C FLUID RETENTION ABDOMINAL PAIN UPPER 2
C FLUID RETENTION GASTRITIS EROSIVE 1
C FLUID RETENTION GASTROINTESTINAL HAEMORRHAGE 1
C FLUID RETENTION HAEMATEMESIS 1
C FLUID RETENTION INSOMNIA 2
C FLUID RETENTION MALLORY-WEISS SYNDROME 1
C FLUID RETENTION RENAL FAILURE ACUTE 1
C HYPERTENSION ABDOMINAL PAIN UPPER 4
C HYPERTENSION GASTRITIS EROSIVE 2
C HYPERTENSION GASTROINTESTINAL HAEMORRHAGE 2
C HYPERTENSION HAEMATEMESIS 2
C HYPERTENSION INSOMNIA 4
C HYPERTENSION MALLORY-WEISS SYNDROME 2
C HYPERTENSION RENAL FAILURE ACUTE 2
C LAXATIVE SUPPORTIVE CARE ABDOMINAL PAIN UPPER 2
C LAXATIVE SUPPORTIVE CARE GASTRITIS EROSIVE 1
C LAXATIVE SUPPORTIVE CARE GASTROINTESTINAL HAEMORRHAGE 1
C LAXATIVE SUPPORTIVE CARE HAEMATEMESIS 1
C LAXATIVE SUPPORTIVE CARE INSOMNIA 2
C LAXATIVE SUPPORTIVE CARE MALLORY-WEISS SYNDROME 1
C LAXATIVE SUPPORTIVE CARE RENAL FAILURE ACUTE 1
C OEDEMA PERIPHERAL ABDOMINAL PAIN UPPER 1
C OEDEMA PERIPHERAL GASTRITIS EROSIVE 1
C OEDEMA PERIPHERAL GASTROINTESTINAL HAEMORRHAGE 1
C OEDEMA PERIPHERAL HAEMATEMESIS 1
C OEDEMA PERIPHERAL INSOMNIA 1
C OEDEMA PERIPHERAL MALLORY-WEISS SYNDROME 1
C OEDEMA PERIPHERAL RENAL FAILURE ACUTE 1
C PAIN ABDOMINAL PAIN UPPER 4
C PAIN GASTRITIS EROSIVE 2
C PAIN GASTROINTESTINAL HAEMORRHAGE 2
C PAIN HAEMATEMESIS 2
C PAIN INSOMNIA 4
C PAIN MALLORY-WEISS SYNDROME 2
C PAIN RENAL FAILURE ACUTE 2
C PROPHYLAXIS HEPATIC FUNCTION ABNORMAL 2
C PSORIASIS DUODENAL ULCER 5
C PSORIASIS GASTRIC ULCER 5
C PSORIASIS HEPATIC FUNCTION ABNORMAL 5
C PSORIASIS INJECTION SITE ERYTHEMA 5
C PSORIASIS INJECTION SITE PAPULE 5
C PSORIASIS INJECTION SITE REACTION 5
C PSORIASIS PSORIASIS 5
C RENAL DISORDER ABDOMINAL PAIN UPPER 2
C RENAL DISORDER GASTRITIS EROSIVE 1
C RENAL DISORDER GASTROINTESTINAL HAEMORRHAGE 1
C RENAL DISORDER HAEMATEMESIS 1
C RENAL DISORDER INSOMNIA 2
C RENAL DISORDER MALLORY-WEISS SYNDROME 1
C RENAL DISORDER RENAL FAILURE ACUTE 1
Ads by Google